Authors
Latest:
Partnership Between Public Health and Pharmacy: Opportunities to Increase Resource Sharing, Efficiency, and Improved Health OutcomesAdditional support is necessary to ensure that infrastructure development continues and that all pharmacists have the necessary tools to continue to provide immunization services.
Latest:
Utilizing Contemporary Art to Transform Health EducationThe perception of creativity has been limited merely to art and innovation, neglecting one of the main sectors that strives for this: education.
Latest:
A Linezolid Prior Authorization Program: Clinical and Economic OutcomesThis study demonstrated that a linezolid PA program did not appear to be associated with a negative impact on medical outcomes and was associated with lower costs.
Latest:
Plethora of Clinical Trials Explore Gastric Cancer TreatmentsPharmacists can play an integral role in collaborating with physicians to manage patient therapy.
Latest:
The Beginning of a MovementIf independents have any chance of survival, we need to get into the game ourselves and teach the public what they don't know about PBMs.
Latest:
Shifting Your Nutrition, Fitness Expectations During Shelter in PlaceWith all the factors of the COVID-19 outbreak taken into consideration, simply maintaining your current body weight and level of health and fitness is a win worth celebrating.
Latest:
Entyvio by Takeda PharmaceuticalsEntyvio, manufactured by Takeda Pharmaceuticals, was approved in May 2014 for the treatment of adult patients with moderate to severe ulcerative colitis or Crohn's disease.
Latest:
LTC Pharmacists Drive Positive Clinical OutcomesStudy also highlights transitions-of-care programs that help patients avoid ED visits or acute care stays.
Latest:
Patient-Centered Care: Give Patients a ShovelWith the New Year approaching, let's resolve to decrease some of the difficulty with anticoagulant medications by welcoming patients and technology into the patient counseling dialogue.
Latest:
Counsel Patients About Diet and NutritionThis therapy is critical for the treatment of common disease states, including diabetes.
Latest:
Trends in Medication Utilization and the Cost of Treatment for GoutWith new drugs in the pipeline and the impact of updated FDA drug safety policies on colchicine, gout may no longer be inexpensive to treat.
Latest:
Potential Gender Differences of Exenatide in Outpatients With Type 2 Diabetes MellitusIn outpatients with type 2 diabetes mellitus, persistent exenatide treatment lowered glycated hemoglobin and hyperglycemia in both genders. Waist circumference and body weight were more reduced in women.
Latest:
Direct and Indirect Cost Burden of Chronic Hepatitis CAn estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.
Latest:
Co-pay Accumulator Programs: Behind the ControversyWith ongoing growth across the board, plan sponsors are continuously searching for ways to minimize the impact on their bottom line.
Latest:
Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid TumorsEli Lilly and Company (NYSE: LLY) and AstraZeneca (NYSE: AZN) today announced that they have entered into a clinical trial collaboration to evaluate safety and preliminary efficacy of their products.
Latest:
Adult Immunizations: Are Your Patients Up-to-Date?In the health-system setting, pharmacists must often prioritize their attention to treating the most acute medical condition a patient presents with; however, it is important to also consider opportunities to prevent disease.
Latest:
Pharmacy Best Practices for Contraceptive Care During COVID-19It’s important that patients understand how their pharmacy can continue to meet their contraceptive needs during the coronavirus disease 2019 (COVID-19) pandemic.
Latest:
A Linezolid Prior Authorization Program: Clinical and Economic OutcomesThis study demonstrated that a linezolid PA program did not appear to be associated with a negative impact on medical outcomes and was associated with lower costs.
Latest:
Fixed-Ratio Combination of Basal Insulin and GLP-1 Receptor AgonistNinety percent of diabetes cases are type 2, which is a major cause of morbidity and mortality.
